Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn

Blood Adv. 2022 May 10;6(9):2893-2896. doi: 10.1182/bloodadvances.2021006865.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Down Syndrome*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Infant, Newborn
  • Leukemoid Reaction*

Supplementary concepts

  • Myeloproliferative Syndrome, Transient